- IDEMIA Partners With JAC to Successfully Test Frictionless Biometric Access Technology at Level5 Stadium in Japan
Rabu, 04 Maret 2020 10:04:00
IDEMIA Partners With JAC to Successfully Test Frictionless Biometric Access Technology at Level5 Stadium in Japan
MorphoWave™ Compact biometric authentication technology was showcased during the final match of the J2 League. The proof of concept included ticketless/handsfree admission for pre-registered customers and food and beverage collection and biometric verification at the pickup counter.
March 03, 2020 09:00 PM Eastern Standard Time
SINGAPORE--(BUSINESS WIRE)--IDEMIA, the global leader in Augmented Identity and Japan Aerospace Corporation (JAC) partnered to demonstrate a proof of concept with MorphoWave™ Compact, a unique award-winning access control biometric device.
A first in Japan, the biometric access technology was successfully tested at Level5 stadium in Fukuoka during the final match of the J2 League between Avispa Fukuoka and Kagoshima United Football Club at the end of 2019.
MorphoWave™ Compact enables four fingerprints to be read in less than one second by a wave of the hand across the device. This biometric access solution enables the stadium to combine speed and convenience with a high level of security within its high traffic environment.
Two use cases were tested during the game:
Ticketless / handsfree admission: pre-registered customers were able to enter the stadium by biometric authentication without a physical ticket
Verifying the identity of the customer by a wave of the hand on the biometric terminal at the food and beverage pick-up counter.
“Our goal is to enable frictionless access everywhere without compromising security,” said Nobuyoshi Nezu, Managing Director and Vice President of Sales for IDEMIA Japan. “IDEMIA has developed MorphoWave™ Compact, a touchless fingerprint device that enables this, by combining a high level of biometric security with a unique user experience, convenience and speed, which is what environments like a stadium need. We are excited to partner with Japan Aerospace Corporation on this very promising case and look forward to a full rollout of our MorphoWave™ devices at Level5 Stadium.” (*).